1 – 36 of 36
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Decreasing early mortality in acute myeloid leukaemia in Sweden 1997–2014 : improving performance status is a major contributing factor
(
- Contribution to journal › Letter
-
Mark
COVID-19—a very visible pandemic
(
- Contribution to journal › Letter
- 2019
-
Mark
Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting
(
- Contribution to journal › Article
- 2017
-
Mark
Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia : A population-based study from the Swedish AML registry
(
- Contribution to journal › Article
- 2016
-
Mark
Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
(
- Contribution to journal › Article
- 2015
-
Mark
Prognostic significance of high hyperdiploid and tri-/tetraploid adult acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry
(
- Contribution to journal › Article
-
Mark
Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.
(
- Contribution to journal › Article
- 2013
-
Mark
High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden : graft-versus-leukemia effect protects against relapse
(
- Contribution to journal › Article
- 2012
-
Mark
Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study
(
- Contribution to journal › Letter
-
Mark
Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?
(
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
(
- Contribution to journal › Article
- 2011
-
Mark
Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: A retrospective study.
(
- Contribution to journal › Letter
-
Mark
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study
(
- Contribution to journal › Article
-
Mark
Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden.
(
- Contribution to journal › Article
-
Mark
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006.
(
- Contribution to journal › Article
- 2010
-
Mark
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study
(
- Contribution to journal › Article
-
Mark
Monoclonal Gammopathy of Undetermined Significance and Risk of Infections A Population Based Study
(
- Contribution to journal › Published meeting abstract
-
Mark
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
(
- Contribution to journal › Article
- 2009
-
Mark
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
(
- Contribution to journal › Article
-
Mark
Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden
(
- Contribution to journal › Article
-
Mark
Risk of plasma cell and lymphoproliferative disorders among 14 621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden
(
- Contribution to journal › Article
-
Mark
Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study
(
- Contribution to journal › Article
-
Mark
Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study
(
- Contribution to journal › Published meeting abstract
-
Mark
Proportion of Adult AML Patient Population Receiving Allogeneic Stem Cell Transplantation and Long-Term Outcome: Real World Data From the Swedish National Acute Leukemia Registry.
(
- Contribution to journal › Published meeting abstract
-
Mark
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study
(
- Contribution to journal › Article
- 2008
-
Mark
Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia
(
- Contribution to journal › Article
-
Mark
Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden
(
- Contribution to journal › Published meeting abstract
- 2006
-
Mark
Chronic lymphocytic leukemia with osteolytic Richter's syndrome mimicking myeloma bone disease shows no over-expression of DKK1
(
- Contribution to journal › Article
-
Mark
Chromosome aberrations including der(6)t(2;6)(p15;p21.3) and der(22)t(3;22)(p21;p11) in the evolution of essential thrombocythemia to myelofibrosis with myeloid metaplasia
(
- Contribution to journal › Article
-
Mark
Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML
(
- Contribution to journal › Article
-
Mark
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy plus G-CSF in patients with chronic myelogenous leukemia in first chronic phase
(
- Contribution to journal › Article
- 1997
-
Mark
Angioid streaks are part of a familial syndrome of dyserythropoietic anaemia (CDA III)
(
- Contribution to journal › Article
- 1995
-
Mark
Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25
(
- Contribution to journal › Article
- 1994
-
Mark
Intravascular haemolysis and increased prevalence of myeloma and monoclonal gammopathy in congenital dyserythropoietic anaemia, type III
(
- Contribution to journal › Article
- 1988
-
Mark
Effects of plasmapheresis on the plasma concentration of proteins used to monitor the disease process in multiple myeloma
(
- Contribution to journal › Article